Free Speech, Due Process and Trial by Jury
There are fundamental changes taking place in healthcare and biotechnology transactions. As in energy deals, those changes involve more than the sums of their bottom lines. Two of the 21 deals in this week's CDT Roundup help make the point.
As the year nears its end and oil prices begin to settle against the demand-threat posed by Omicron, it's a good time to point up the most obvious change in energy deals: a surge in equity investment in renewables and energy transition technologies. The change is real and, according to a new report from Vinson & Elkins, even O&G giants are acknowledging it. That report, and last week's transactions are all in this week's slightly tardy CDT Roundup.
Just because concerns about O&G prices have been replaced by concerns about ESG doesn't mean that the old ways have vanished. For instance, hydraulic fracturing — in case you were wondering — never really disappeared. Not only is fracking back, next year could well bring a healthy rebound for use of the controversial process. Details on that, and the names of lawyers involved in last week's transactions are in this week's CDT Roundup.
The non-stop, day-to-day challenges posed by the pandemic and the feverish activity by private equity firms in the healthcare space have kept Lisa Prather exceptionally busy over the past 20 months. In this Q&A, she describes how her practice group became "instantly busier" when the pandemic hit, what trends are here to stay and the kinds of deals she expects to see more of.
With commodities pricing still on the volatile side, PE and VC deals are getting a lot of attention. But plodding along with them is real asset investing, as a new report by PitchBook reveals. And inside that space, infrastructure deals are taking off, and maybe not for the reasons you may think. That, and a look at last week's transactions, in the CDT Roundup.
Global M&A is at record levels. Private equity deals, too. And tech is leading the way. Though energy is still king in Texas, technology (and PE investments in technology) are setting the pace for the kind of year people may remember when there's a new election for king. More on that and all the deals from a three-day work week in the CDT Roundup.
Historically, Texas dealmaking has run on energy. But dealmaking, in turn, runs on optimism. And if the new Dykema Survey of M&A dealmakers is any measure, there will be much to celebrate this time next year. The CDT Roundup looks at the survey's surprising results as well the deals involving Texas lawyers last week. There were plenty of them.
Joel Mack is a rare find in Big Law. He started at Latham & Watkins 35 years ago, and 35 years later, he's still there. His LinkedIn job list is as short as a 24-year-old associate: college, law school, Latham. But his client list reads like a stock exchange, and his deal résumé like a history of environmental law. Nushin Huq tells his story and reveals the quiet passion for service that keeps him flying high.
© Copyright 2025 The Texas Lawbook
The content on this website is protected under federal Copyright laws. Any use without the consent of The Texas Lawbook is prohibited.
